|
What’s Inside: Where to Meet Us at #BIO2024; Onchilles Pharma Shows Promising Potential for Broad Cancer Treatment; Source Top Talent Through Our New Career Hub; and more.
|
We’re championing the progress made by California’s life science community and want to hear about your company’s latest scientific breakthrough, investment milestone, or commitment to creating positive change for our industry. Submit your story here for possible inclusion in an upcoming issue. |
|
|
What’s Happening at Biocom California
|
|
Make Biocom California’s Space Your Home Base at #BIO2024
We invite all members attending #BIO2024 in San Diego this June to leverage our 600-square-foot booth, charging stations and private conference room. Centrally located in the California Pavilion, the Biocom California booth (#2625) offers an ideal place to network, hold one-on-one partnering discussions, and regroup between activities. Stay informed on our week’s hosted activities by bookmarking this page, including applying to pitch at our Venture Hub Showcase on June 3, rocking out at our Summer Concert at the Rady Shell on June 4, and joining us for an International Connections Reception with our partners from Japan, Korea, Australia and France the morning of June 5. Later that day, don’t miss a panel moderated by Biocom California Institute on “ Diversifying the Talent Pipeline.”
|
Exclusive for Members: Our New Life Science Job Board
For 29 years, we have fostered the growth and prosperity of the life science industry in California. Today, we are excited to announce our next advancement in this mission with the launch of our Biocom California Institute Career Hub; a new exclusive membership benefit that aims to amplify the visibility of our life science companies, all while facilitating connections with talent searching for the next step in their careers. The Career Hub is the nation’s largest job board for life science and serves as the premier recruitment platform for members actively seeking to diversify and expand their workforce. We invite all members to join us for a webinar May 2 at 9:30 a.m. to learn more about this AI-backed program.
|
|
|
Celebrating Earth Day with Back-to-Back Events Along the Coast
We were proud to welcome members to our statewide Earth Day celebrations this month—an annual opportunity to unite the life science community in environmental awareness and action. We heard from experts as they explored sustainable innovation in life science, offering compelling industry outlooks on collective action and tangible impact for both small and large companies. In the Bay Area, we hosted a panel on fostering a circular mindset and reducing waste, with novel approaches in recycling lab plastics and supply-chain management. In San Diego, our 8th annual Earth Day Sustainability Reception included a keynote from Thermo Fisher Scientific, followed by a lively panel discussion featuring representatives from Pfizer, My Green Lab, Veolia North America, I Love a Clean San Diego, Vertex Pharmaceuticals, and Novartis.
|
|
|
|
|
|
|
Industry Intelligence & Member Moments
|
- Bristol Myers Squibb and Cellares announced a $380 million worldwide capacity reservation and supply agreement for the manufacture of CAR T cell therapies to bring the promise of cell therapy to more patients, faster.
- Cytiva unveils new single-use magnetic mixing system, designed to address challenges in large-scale mAb, vaccine and genomic medicine manufacturing processes.
- Kumquat Biosciences established a strategic and exclusive collaboration with Takeda to develop and commercialize a novel immuno-oncology small molecule inhibitor as a mono- and/or combination-therapy.
- Kura Oncology has been granted Breakthrough Therapy Designation from the FDA for its investigational drug, ziftomenib, for the treatment of patients with relapsed/refractory NPM1-mutant acute myeloid leukemia.
- My Green Lab launched Impact Laboratories, a new commercial subsidiary which will advance My Green Lab’s certification program through third-party verification.
- Onchilles Pharma shared promising data from its first-in-class oncology programs that harness the potent efficacy of the innate immune system and have the potential to become a major new treatment modality for a wide range of cancer types.
- Palisade Bio entered into a strategic collaboration with Strand Life Sciences aimed at advancing precision medicine for ulcerative colitis therapy.
- TriLink BioTechnologies announced the grand opening of its new 32,000-square-foot facility in San Diego for late-phase mRNA drug substance production.
- UC San Diego Division of Extended Studies partnered with the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences to offer a new course, Pharmaceutical and Biotech Drugs Journey: From Preclinical to Patients.
- USC released a study linking the lack of diversity in Alzheimer’s disease clinical trials to differences in amyloid levels.
|
|
Biocom California Hosts Roundtable with ARPA-H
On April 4, Biocom California hosted a roundtable with the Advanced Research Projects Agency for Health (ARPA-H) Director Renee Wegrzyn and her team. San Diego life science companies, research institutes and universities had the unique opportunity to meet with the newest federal agency to discuss its research funding model and engage directly with high-level ARPA-H officials. The popular event was at maximum capacity with over 40 attendees.
|
|
Roundtable with South San Francisco Mayor & Vice Mayor
On March 7, Biocom California held a roundtable with South San Francisco Mayor James Coleman, Vice Mayor Eddie Flores and the city’s economic development team to discuss city and life science industry priorities. A variety of issues were covered, including workforce housing, access to transit, future life science developments and city services. We thank the city team and our members for joining us for this important exchange of information and ideas. To join future events, contact Christy Shirilla.
|
|
LA Mayor Delivers State of the City Address
In her State of the City address, LA Mayor Karen Bass spoke on the city’s budget shortfall and upcoming Olympic Games, but focused mostly on addressing homelessness. She unveiled LA4LA, a capital campaign aiming to raise $400 million through public-private partnerships to build housing and expand services for the homeless population. Mayor Bass emphasized the urgency of addressing the crisis and called for community support to create sustainable solutions for those in need.
|
|
Sorrento Valley Coaster Shuttle Service to Continue
On April 18, the North County Transit District (NCTD) Board of Directors unanimously approved continuing shuttle service from the Sorrento Valley Coaster station to area employers, and to UTC and Mira Mesa. Biocom California was present to speak in support of the item, and NCTD praised our advocacy efforts around this issue. This is an important transit win for life science employees and helps all stakeholders reach their climate goals.
|
|
Biocom California
For over 29 years, Biocom California has helped move the life science industry forward with transformative resources that enable companies to make meaningful connections. With a membership base of over {{{dynamic_content_1600}}} companies, we connect our members to each other so they can collaborate and work stronger and smarter together. We connect organizations to capital investment and purchasing solutions so they can grow faster and work more efficiently. We’re their link to advocacy that fights for innovation and we provide an environment where their business and talent can thrive. Biocom California is how the life science industry gets connected.
|
|
|
